Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015
Summary
Global Markets Directs, Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015, provides an overview of the Zeria Pharmaceutical Co., Ltd.s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Zeria Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Zeria Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Zeria Pharmaceutical Co., Ltd.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Zeria Pharmaceutical Co., Ltd.s pipeline products
Reasons to buy
- Evaluate Zeria Pharmaceutical Co., Ltd.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Zeria Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Zeria Pharmaceutical Co., Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Zeria Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zeria Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Zeria Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Zeria Pharmaceutical Co., Ltd. Snapshot 5
Zeria Pharmaceutical Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Zeria Pharmaceutical Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Zeria Pharmaceutical Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Zeria Pharmaceutical Co., Ltd. - Pipeline Products Glance 14
Zeria Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
Zeria Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Zeria Pharmaceutical Co., Ltd. - Drug Profiles 17
acotiamide hydrochloride 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
polaprezinc 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Z-100 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ZOSA-0 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
E-3710 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Z-360 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
ferric carboxymaltose 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Zeria Pharmaceutical Co., Ltd. - Pipeline Analysis 26
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Target 26
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 27
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 28
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 29
Zeria Pharmaceutical Co., Ltd. - Recent Pipeline Updates 30
Zeria Pharmaceutical Co., Ltd. - Dormant Projects 32
Zeria Pharmaceutical Co., Ltd. - Discontinued Pipeline Products 33
Discontinued Pipeline Product Profiles 33
acotiamide hydrochloride 33
Zeria Pharmaceutical Co., Ltd. - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 37
Disclaimer 38
List Of Tables
Zeria Pharmaceutical Co., Ltd., Key Information 5
Zeria Pharmaceutical Co., Ltd., Key Facts 5
Zeria Pharmaceutical Co., Ltd. - Pipeline by Indication, 2015 7
Zeria Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015 8
Zeria Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Zeria Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015 10
Zeria Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015 11
Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2015 12
Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2015 13
Zeria Pharmaceutical Co., Ltd. - Phase III, 2015 14
Zeria Pharmaceutical Co., Ltd. - Phase II, 2015 15
Zeria Pharmaceutical Co., Ltd. - Phase I, 2015 16
Zeria Pharmaceutical Co., Ltd. - Pipeline by Target, 2015 26
Zeria Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2015 27
Zeria Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2015 28
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2015 29
Zeria Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2015 30
Zeria Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2015 32
Zeria Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2015 33
Zeria Pharmaceutical Co., Ltd., Other Locations 34
Zeria Pharmaceutical Co., Ltd., Subsidiaries 35
List Of Figures
Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Zeria Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015 8
Zeria Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Zeria Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015 10
Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2015 12
Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2015 26
Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015 27
Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 28
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 29
